USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Gene Therapy Market By Vector (Viral & Non-Viral), By Delivery Mode (In Vivo & Ex Vivo), By Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026

Covid-19

Global Gene Therapy Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[205+ Pages Report] We at Facts & Factors have recently published a report titled “Global Gene Therapy Market” that encompasses the spectacle of the market in an analytical and comprehensive manner. We at Facts & Factors estimate that the gene therapy market will be valued at USD 12.9 Billion in the year 2026 from an initial value of USD 2.7 Billion in the year 2020 at a CAGR value of 22.3%.

logoMarket Overview

Gene therapy is a medical binomial that allows for the modification of a person’s genes in order to develop antibodies for treating or curating diseases. Gene therapies can work by employing several mechanisms such as replacing a disease-causing gene with a healthy variation of the gene or by inactivating a disease-causing gene that does not have the proper functionality. Additionally, a mechanism can include introducing a newly modified gene into the body for further eliminating a disease. The variety of gene therapies that are currently available are plasmid DNA, viral vectors, bacterial vectors, human gene-editing technology, and patient-derived cellular gene therapy products, to name a few.

logoIndustry Growth Factors

The primary driving factors for the significant growth of the global gene therapy market are the increasing prevalence of cancer and other targeted disorders coupled with the rising availability of measures. Additionally, gene therapy is being granted several reimbursements from various insurance carriers which increases the revenue stream that can be generated for the market during the forecast period. Rising funding for gene therapy research coupled with the rising adoption of gene therapy therapeutics is expected to increase the footprint of the global gene therapy market during the forecast period. A dynamic competitive nature is expected to drive the market due to several initiatives that are undertaken by the key market players such as the biopharma companies.

The insurgence of the current pandemic is expected to create a positive impact on the global gene therapy market during the forecast period. The market is expected to increase in boundaries due to the added intervention of life-threatening diseases such as heart diseases, AIDS, cystic fibrosis, and age-related disorders. Rising investment in research and development activities is further expected to curate a larger market revenue for the global gene therapy market during the forecast period. However, high prices and irregular availability is expected to dim the market growth to a slower rate during the forecast period.

logoSegmentation Analysis

The global gene therapy market can be segmented into vectors, delivery methods, indications, and regions.

The global gene therapy market can be divided into viral and non-viral vectors on the basis of vectors. The segment pertaining to non-viral vectors is expected to witness the largest market share during the advent of the forecast owing to technological advancements for physicochemical approaches in materials such as lipid, naked DNA, chromosomes, plasmid, cationic polymers, and conjugate complexes to name a few. The global gene therapy market can be fragmented into in vivo and ex vivo on the basis of delivery mode. The ex vivo segment is expected to occupy the largest market share during the advent of the forecast owing to a safer mode of operation and easy deliverables to name a few. The global gene therapy market can be broken down into neurological diseases, cancer, Duchenne muscular dystrophy, hepatological diseases, and others on the basis of indication. The segment pertaining to cancer is expected to witness the largest market share during the advent forecast period owing to the rising approval of gene therapies for the treatment of cancer coupled with the increasing prevalence of hematologic cancers to name a few.

Report Attribute

Details

Market Size in 2020

USD 2.7 Billion

Projected Market Size in 2026

USD 12.9 Billion

CAGR Growth Rate

22.3%

Base Year

2020

Forecast Years

2021-2006

Key Market Players

Bluebird Bio, Inc., TaxusCardium Pharmaceutical Group, Inc., UniQure N.V., Shire Plc, Cellectis S.A. and Others

Key Segments

Vectors, Delivery Mode, Indications, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logo Regional Analysis

North America is expected to witness the largest market share during the forecast period in terms of global revenue contribution. The factors that contribute to the market dominance on a global scale can be attributed to the rising prevalence of chronic diseases coupled with a high and growing healthcare expenditure to name a few. Additionally, integration of advanced healthcare infrastructure coupled with readily available reimbursements measures are expected to increase the footprint of the gene therapy market in the region. Increasing key market players in the region coupled with favorable regulatory approval are expected to project the gene therapy market on a steadfast path during the forecast period.

logo Competitive Players

The key market participants for the global gene therapy market are REGENBIO, Inc., Oxford BioMedicaPlc, Dimension Therapeutics, Inc., Bristol-Myers Squibb Company, SANOFI, Applied Genetics Technologies Corporation, Bluebird Bio, Inc., TaxusCardium Pharmaceutical Group, Inc., UniQure N.V., Shire Plc, Cellectis S.A., Sangamo Therapeutics, Inc., Gilead Lifesciences, Inc., and Shanghai Sunway Biotech Co. Ltd., among others.

logo By Vectors Segment Analysis

  • Viral
    • Retroviral Vector
      • Gammaretroviral Vector
      • Lentiviral Vector
    • Adeno-Associated Vector
    • Other Viral Vectors
  • Non-Viral
    • Oligonucleotides

logo By Delivery ModeSegment Analysis

  • In Vivo
  • Ex Vivo

logo By IndicationSegment Analysis

  • Neurological Diseases
  • Cancer
  • Duchenne Muscular Dystrophy
  • Hepatological Diseases
  • Others

logo By Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Covid-19

Gene Therapy Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • REGENBIO Inc.
  • Oxford BioMedicaPlc
  • Dimension Therapeutics Inc.
  • Bristol-Myers Squibb Company
  • SANOFI
  • Applied Genetics Technologies Corporation
  • Bluebird Bio Inc.
  • TaxusCardium Pharmaceutical Group Inc.
  • UniQure N.V.
  • Shire Plc
  • Cellectis S.A.
  • Sangamo Therapeutics Inc.
  • Gilead Lifesciences Inc.
  • Shanghai Sunway Biotech Co. Ltd.

Frequently Asked Questions

The governing factors that are responsible for the extensive growth of the global gene therapy market are the increasing prevalence of cancer and other targeted disorders coupled with rising availability measures to name a few.
According to Facts & Factors, global demand for gene therapy market is expected to generate revenue of around USD 12.9 Billion by end of 2026, growing at a CAGR of around 22.3% between 2021 and 2026.
North America is expected to witness the largest market share during the advent of the forecast owing to the rising prevalence of chronic diseases coupled with a high and growing healthcare expenditure to name a few.
The key participants in the global gene therapy market are REGENBIO, Inc., Oxford BioMedica Plc, Dimension Therapeutics, Inc., Bristol-Myers Squibb Company, SANOFI, and Applied Genetics Technologies Corporation, to name a few.
why choose fnf
key questions answers

Related Reports

report img

Drug Delivery in Cancer Market Report 2022–2028

[205+ Pages Report] According to Facts and Factors, the global drug delivery in cancer market was valued at USD 1527.40 million in 2021 and is predicted to increase at a CAGR of 6.70 % to USD 2253.92 million by 2028. The study examines the market in terms of revenue in each of the major regions, w...

Published Date : 13-Jun-2022 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

Breast Biopsy Market Report 2022 – 2028

[227+ Pages Report] According to Facts and Factors, the Global Breast Biopsy Market was valued at USD 702.13 million in 2021 and is predicted to increase at a CAGR of 7.3% to USD 1,109.35 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are cla...

Published Date : 03-Jun-2022 | | Category : | Pages : 227 | Format : Read more

Inquiry for Buying Request Sample